Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Curetis N.V.. (4/27/18). "Press Release: Curetis to Raise EUR 4.1 Million in Equity Offering with Access to Additional USD 10 million in Equity Over 36 Months [Not for United States, Australia, Canada, Japan, or any other jurisdiction where unlawful]". A

Region Region United States (USA)
Organisations Organisation Curetis GmbH
  Group OpGen (Group)
  Organisation 2 Global Corporate Finance (GCF) (US)
Products Product Unyvero molecular diagnostics platform
  Product 2 investment banking
Index terms Index term Curetis–SEVERAL: investment, 201804 capital increase €4.1m offering of 854k new ordinary shares at €4.8/share to qualified EU + US investors
  Index term 2 Curetis–Global Corporate Finance: investment, 201804–202103 equity facility $10m solely at Curetis request up to 36 months at pre-agreed floor pricing
Persons Person Schacht, Oliver (Curetis 201012– CEO before Epigenomics CFO)
  Person 2 Weß, Ludger (akampion before 2001–2006 BioCentury Senior Editor before Financial Times Deutschland)
     


   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for OpGen (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px




» top